Table 4 Effects of insulin and intralipid infusion in control and PCOS subjects after exercise

CTRP2 (ng/mL)

0

1.7 ± 0.6

1.7 ± 0.6

1.7 ± 0.5

1.6 ± 0.6

3H

1.7 ± 0.6

1.8 ± 0.7

3.2 ± 1.4^a,d

3.4 ± 1.2^a,d

5H

2.1 ± 1.4

2.3 ± 0.8

3.6 ± 1.6^a

3.5 ± 1.1^a,d

CTRP9 (ng/mL)

0

59.9 ± 37.4

54.3 ± 23.9

66.1 ± 27.7

65.8 ± 17.5

3H

80.4 ± 49.8

70.1 ± 17.6

67.7 ± 34.8

67.5 ± 22.3

5H

74.5 ± 49.2

69.7 ± 24.4

60.1 ± 44.9

59.5 ± 14.9

GDF8 (ng/mL)

0

1.3 ± 0.4

1.6 ± 0.6

1.6 ± 0.9

1.6 ± 0.9

3H

1.2 ± 0.3

1.5 ± 0.4

2.5 ± 0.8^a,d

2.6 ± 1.0^a,d

5H

1.0 ± 0.3^a,b

1.3 ± 0.5

2.1 ± 0.9^d

2.2 ± 1.1^a,b,d

GDF15 (ng/mL)

0

0.5 ± 0.3

0.6 ± 0.2

0.7 ± 0.2

0.7 ± 0.2

3H

0.3 ± 0.2^a

0.6 ± 0.5

0.5 ± 0.4

0.5 ± 0.4

5H

0.5 ± 0.3^b

0.9 ± 0.4^b,c

0.9 ± 0.9

1.1 ± 0.9^b